Home › Targets › TGF-β
TGF-β (3 companies · 9 programs)
Companies with an active program directed at TGF-β.
- ficerafusp alfa — Head and Neck Squamous Cell Carcinoma Phase 2
- ficerafusp alfa — Colorectal Cancer Phase 1
- ficerafusp alfa — Cutaneous Squamous Cell Carcinoma Phase 1
- ficerafusp alfa — Anal Squamous Cell Carcinoma Phase 1
- rinvatercept — Duchenne Muscular Dystrophy Phase 2
- elritercept — Myelodysplastic Syndromes Phase 3
- elritercept — Myelofibrosis Phase 3
- rinvatercept — Amyotrophic Lateral Sclerosis Phase 1
